Renin–angiotensin system inhibitor use and colorectal cancer risk and mortality: A dose–response meta analysis

OBJECTIVE: This study was undertaken to determine whether use of the renin–angiotensin system (RAS) inhibitors would increase colorectal cancer morbidity and mortality. METHODS: Databases were electronically searched to collect data of RAS use and colorectal cancer morbidity and mortality from incep...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xia, Yi, Chang-hong, Ya, Kuang-guan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338647/
https://www.ncbi.nlm.nih.gov/pubmed/32627649
http://dx.doi.org/10.1177/1470320319895646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338647/
https://www.ncbi.nlm.nih.gov/pubmed/32627649
http://dx.doi.org/10.1177/1470320319895646

Ejemplares similares